Heterotopic Ossification in Hip Arthroscopy: an Updated Review
- PMID: 30810970
- PMCID: PMC6542881
- DOI: 10.1007/s12178-019-09543-9
Heterotopic Ossification in Hip Arthroscopy: an Updated Review
Abstract
Purpose of review: Heterotopic ossification (HO) in hip arthroscopy is a common post-operative complication. This review was undertaken to provide an update (2014 present) on the current literature regarding HO in hip arthroscopy.
Recent findings: Risk factors for HO post-hip arthroscopy include male gender, mixed impingement, picture, and the size of CAM resection. HO prophylaxis with NSAIDs has been proven to decrease the rate of HO post-hip arthroscopy; however, there is inherent risk to long-standing NSAIDs therapy. HO post-hip arthroscopy is not uncommon as a radiological finding, but symptomatic HO post-hip arthroscopy requiring revision surgery is a rare event, at < 1%. The outcomes for revision surgery for HO excision have fair outcomes. The hip arthroscopist should stratify their patients based on known risk factors, and determine whether NSAIDs prophylaxis is warranted.
Keywords: Complication; Heterotopic ossification; Hip arthroscopy; NSAIDs; Prophylaxis; Revision surgery.
Conflict of interest statement
Adrian Z. Kurz, Eugenie LeRoux, Michael Riediger, Ryan Coughlin, Nicole Simunovic, and Andrew Duong each declare no potential conflicts of interest.
Jovan R. Laskovski reports personal fees from Smith and Nephew and Conmed Linvatec.
Olufemi R. Ayeni is on the speakers’ bureaus for Conmed and Smith and Nephew. Dr. Ayeni is a section editor for
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
